Denali Therapeutics Inc. · NASDAQ:DNLI

Baillie Gifford & Co reported a 5.60% stake in Denali Therapeutics Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 8, 2025

Baillie Gifford & Co reported a 5.60% stake in Denali Therapeutics Inc., 2,198,891 shares, as a passive investor on Jun 30, 2025. Filed Aug 8, 2025 (Schedule 13G).

Stake
5.60%
Shares
2,198,891
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BAILLIE GIFFORD & CO5.60%2,198,891

Source

View original at SEC

Related